Clinical Trial Update: Bosentan Therapy in Children With Functional Single Ventricle [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial of bosentan for functional single ventricle has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Functional Single Ventricle

Drugs mentioned

• bosentan (Tracleer) (bosentan)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Congenital Heart Defects, Functional Single Ventricle | Phase 2 | Status: COMPLETED